Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Report 2018

Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Report 2017

1 Vasomotor Symptoms of Menopause Treatment Overview

1.1 Product Overview and Scope of Vasomotor Symptoms of Menopause Treatment

1.2 Classification of Vasomotor Symptoms of Menopause Treatment by Product Category

1.2.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (Sales) Comparison by Types (2012-2022)

1.2.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Estetrol

1.2.4 Fezolinetant

1.2.5 FP-101

1.2.6 HBN-2

1.2.7 Others

1.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market by Application/End Users

1.3.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (Volume) and Market Share Comparison by Applications (2012-2022)

1.3.2 Hospital

1.3.3 Homecare

1.3.4 Clinic

1.4 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market by Region

1.4.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (Value) Comparison by Region (2012-2022)

1.4.2 China Status and Prospect (2012-2022)

1.4.3 Japan Status and Prospect (2012-2022)

1.4.4 South Korea Status and Prospect (2012-2022)

1.4.5 Taiwan Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.4.7 Southeast Asia Status and Prospect (2012-2022)

1.4.8 Australia Status and Prospect (2012-2022)

1.5 Asia-Pacific Market Size (Value and Volume) of Vasomotor Symptoms of Menopause Treatment (2012-2022)

1.5.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2022)

1.5.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Competition by Players/Suppliers, Region, Type and Application

2.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Competition by Players/Suppliers

2.1.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue and Share by Players/Suppliers (2012-2017)

2.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment (Volume and Value) by Type

2.2.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Type (2012-2017)

2.2.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Type (2012-2017)

2.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment (Volume) by Application

2.4 Asia-Pacific Vasomotor Symptoms of Menopause Treatment (Volume and Value) by Region

2.4.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Region (2012-2017)

2.4.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Region (2012-2017)

3 China Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)

3.1 China Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)

3.1.1 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)

3.1.2 China Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)

3.1.3 China Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)

3.2 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type

3.3 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

4 Japan Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)

4.1 Japan Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)

4.1.1 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)

4.1.2 Japan Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)

4.1.3 Japan Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)

4.2 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type

4.3 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

5 South Korea Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)

5.1 South Korea Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)

5.1.1 South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)

5.1.2 South Korea Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)

5.1.3 South Korea Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)

5.2 South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type

5.3 South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

6 Taiwan Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)

6.1 Taiwan Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)

6.1.1 Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)

6.1.2 Taiwan Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)

6.1.3 Taiwan Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)

6.2 Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type

6.3 Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

7 India Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)

7.1 India Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)

7.1.1 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)

7.1.2 India Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)

7.1.3 India Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)

7.2 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type

7.3 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

8 Southeast Asia Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)

8.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)

8.1.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)

8.1.2 Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)

8.1.3 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)

8.2 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type

8.3 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

9 Australia Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)

9.1 Australia Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)

9.1.1 Australia Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)

9.1.2 Australia Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)

9.1.3 Australia Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)

9.2 Australia Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type

9.3 Australia Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

10 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Players/Suppliers Profiles and Sales Data

10.1 Amgen Inc.

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 EndoCeutics, Inc.

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Euroscreen S.A.

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 MenoGeniX, Inc.

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Mithra Pharmaceuticals S.A.

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Pherin Pharmaceuticals, Inc.

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.6.2.1 Product A

10.6.2.2 Product B

10.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Pivot Pharmaceuticals Inc

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.7.2.1 Product A

10.7.2.2 Product B

10.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Radius Health, Inc.

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.8.2.1 Product A

10.8.2.2 Product B

10.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 TherapeuticsMD, Inc.

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification

10.9.2.1 Product A

10.9.2.2 Product B

10.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

11 Vasomotor Symptoms of Menopause Treatment Manufacturing Cost Analysis

11.1 Vasomotor Symptoms of Menopause Treatment Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Vasomotor Symptoms of Menopause Treatment Major Manufacturers in 2016

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Forecast (2017-2022)

15.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Price Forecast (2017-2022)

15.1.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast (2017-2022)

15.1.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2017-2022)

15.1.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2017-2022)

15.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

15.2.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast by Region (2017-2022)

15.2.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast by Region (2017-2022)

15.2.3 China Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.4 Japan Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.5 South Korea Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.6 Taiwan Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.7 India Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.8 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.9 Australia Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)

15.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Price Forecast by Type (2017-2022)

15.3.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Forecast by Type (2017-2022)

15.3.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Forecast by Type (2017-2022)

15.3.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Price Forecast by Type (2017-2022)

15.4 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology/Research Approach

17.1.1 Research Programs/Design

17.1.2 Market Size Estimation

17.1.3 Market Breakdown and Data Triangulation

17.2 Data Source

17.2.1 Secondary Sources

17.2.2 Primary Sources

17.3 Disclaimer

Figure Product Picture of Vasomotor Symptoms of Menopause Treatment

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (Product Category) in 2016

Figure Estetrol Product Picture

Figure Fezolinetant Product Picture

Figure FP-101 Product Picture

Figure HBN-2 Product Picture

Figure Others Product Picture

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Application (2012-2022)

Figure Asia-Pacific Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Homecare Examples

Table Key Downstream Customer in Homecare

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) by Region (2012-2022)

Figure China Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure South Korea Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Australia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate (2012-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Major Players Product Sales Volume (K Pcs)(2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Share by Players/Suppliers

Figure 2017 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Share by Players/Suppliers

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Major Players Product Revenue (Million USD) 2012-2017

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Share by Players

Figure 2017 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Share by Players

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Type (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Share by Type (2012-2017)

Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Type (2012-2017)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Growth Rate by Type (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Type (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Vasomotor Symptoms of Menopause Treatment by Type (2012-2017)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate by Type (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Market Share by Region (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Share by Region (2012-2017)

Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Region (2012-2017)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Market Share by Region in 2016

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Region (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Vasomotor Symptoms of Menopause Treatment by Region (2012-2017)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Region in 2016

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Market Share by Application (2012-2017)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Application (2012-2017)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2012-2017)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2012-2017)

Figure China Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure China Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)

Figure China Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)

Table China Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)

Table China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)

Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016

Table China Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Applications (2012-2017)

Table China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)

Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016

Figure Japan Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)

Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)

Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)

Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016

Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Applications (2012-2017)

Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)

Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016

Figure South Korea Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure South Korea Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)

Figure South Korea Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)

Table South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)

Table South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)

Figure South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016

Table South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Applications (2012-2017)

Table South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)

Figure South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)

Table Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)

Table Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016

Table Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Applications (2012-2017)

Table Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016

Figure India Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure India Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)

Figure India Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)

Table India Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)

Table India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)

Figure India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016

Table India Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2017)

Table India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)

Figure India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)

Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)

Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016

Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Applications (2012-2017)

Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016

Figure Australia Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Australia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)

Figure Australia Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)

Table Australia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)

Table Australia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)

Figure Australia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016

Table Australia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Applications (2012-2017)

Table Australia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)

Figure Australia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016

Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Basic Information List

Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List

Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)

Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in Asia-Pacific (2012-2017)

Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in Asia-Pacific (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price (USD/Pcs) Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Vasomotor Symptoms of Menopause Treatment

Figure Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment

Figure Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis

Table Raw Materials Sources of Vasomotor Symptoms of Menopause Treatment Major Manufacturers in 2016

Table Major Buyers of Vasomotor Symptoms of Menopause Treatment

Table Distributors/Traders List

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) and Trend Forecast (2017-2022)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) Forecast by Region (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share Forecast by Region (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share Forecast by Region in 2022

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Region (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Region (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Region in 2022

Figure China Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure China Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure South Korea Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure South Korea Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Taiwan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure India Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Australia Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Australia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Type (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Type (2017-2022)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Type (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Type (2017-2022)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) Forecast by Type (2017-2022)

Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Application (2017-2022)

Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources